跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,981 条关于
“ribonucleotide reductase inhibitor”
全部
19,981
临床试验
9,820
药物
4,070
机构
20
资讯
6,071
11个月前
Phase 2 Trial Shows 70% Response Rate for Novel Combination Therapy in Advanced Neuroendocrine Tumors
3年前
Nanopharmaceutics Completes Enrollment in Phase 2 Neuroendocrine Tumor Study Combining Triapine with Lutetium Lu 177 Dotatate
去年
Nanopharmaceutics Completes Phase II Enrollment for Triapine Combination Therapy in Neuroendocrine Tumors
去年
Govorestat: FDA Approval Status and Its Role in Treating Galactosemia
去年
Applied Therapeutics Awaits FDA Decision on Govorestat for Galactosemia
6个月前
Cutia Therapeutics Receives NMPA Approval for Topical Dutasteride Clinical Trial in Androgenetic Alopecia
去年
Applied Therapeutics' Govorestat Nears Potential Approval for Galactosemia and SORD Deficiency
去年
Applied Therapeutics to Present Extended INSPIRE Trial Data for Govorestat in SORD Deficiency at PNS Annual Meeting
9个月前
Cycle Pharmaceuticals Acquires Applied Therapeutics in $0.088 Per Share Deal to Advance Rare Disease Pipeline
去年
FDA Rejects Applied Therapeutics' Govorestat for Classic Galactosemia, Citing Clinical Deficiencies
第 1 页，共 608 页
上一页
下一页
